Inhalable Nanomaterial Discoveries for Lung Cancer Therapy: A Review

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Lung cancer is a leading cause of cancer-related deaths globally.
• Conventional chemotherapy for lung cancer faces challenges like limited efficacy and systemic side effects.
• Pulmonary drug delivery using nanomaterials presents a targeted and efficient treatment strategy.

Purpose of the Study:

• To review the current research and clinical applications of inhalable nanomaterials for lung cancer treatment.
• To highlight advances in pulmonary drug delivery devices and nanomaterial formulations.
• To identify challenges and propose strategies for the clinical translation of these therapies.

Main Methods:

• Literature review of basic research and clinical studies on inhalable nanomaterials for lung cancer.
• Analysis of pulmonary drug delivery systems, including devices and nanomaterial types.
• Discussion of challenges and potential solutions for clinical implementation.

Main Results:

• Inhalable nanomaterials demonstrate potential for targeted lung cancer therapy with reduced systemic toxicity.
• Advancements in pulmonary devices and nanomaterial design enhance drug delivery efficiency.
• Significant hurdles remain in translating these promising findings into widespread clinical practice.

Conclusions:

• Inhalable nanomaterials represent a significant advancement in targeted lung cancer treatment.
• Overcoming challenges in formulation, delivery, and regulatory processes is crucial for clinical success.
• Further research and development are needed to fully realize the potential of pulmonary nanomedicine for lung cancer.